Indian acquisition for Barentz
Barentz International has acquired Anshul Life Sciences, an Indian speciality chemicals distributor to the pharmaceuticals, personal care and other markets. Terms were not disclosed. CEO Nagarajan Kailasam and the rest of the Anshul team will continue to manage the day-to-day business operations.
Barentz commented that this establishes a major life science distribution platform in India and should “open a realm of strategic opportunities for growth across the country and the broader Asia Pacific region”. Anshul adds more excipients, APIs and intermediates to its pharma portfolio while widening the personal care offer.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
